A risk assessment tool for the virtual screening of metal oxide nanoparticles through enalos insiliconano platform

Current Topics in Medicinal Chemistry

Volumn 15, Issue 18, 2015, Pages 1827-1836

  Melagraki, Georgia ^a,b   Afantitis, Antreas ^a,b  

^a NOVAMECHANICS LTD   (Cyprus)

^b InSilicoLab LP   (Greece)

Author keywords

Enalos InSilicoNano platform; Nanoparticles; Quantitative nano structure activity relationship (QNAR); Risk assessment; Toxicity; Web service

Indexed keywords

METAL OXIDE NANOPARTICLE; NANOCOATING; NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; METAL; OXIDE;

ACCURACY; ALGORITHM; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL MODIFICATION; COMPUTER PREDICTION; COMPUTER PROGRAM; CYTOTOXICITY; DRUG DESIGN; DRUG SAFETY; DRUG SCREENING; EC50; ESCHERICHIA COLI; INTERNET; MATHEMATICAL MODEL; MEMBRANE DAMAGE; MULTIPLE LINEAR REGRESSION ANALYSIS; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PNEUMONIA; QUANTITATIVE NANOSTRUCTURE ACTIVITY RELATIONSHIP; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE TOXICITY RELATIONSHIP; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; VALIDATION STUDY; ZETA POTENTIAL; ADVERSE EFFECTS; HUMAN; NANOTECHNOLOGY; PRECLINICAL STUDY;

DRUG EVALUATION, PRECLINICAL; HUMANS; METALS; NANOPARTICLES; NANOTECHNOLOGY; OXIDES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RISK ASSESSMENT;

EID: 84934756718     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150506144536     Document Type: Article

References (49)

1. Gajewicz, A.; Rasulev, B.; Dinadayalane, T. C.; Urbaszek, P.; Puzyn, T.; Leszczynska, D.; Leszczynsk, J. Advancing risk assessment of engineered nanomaterials: Application of computational approaches. Adv. Drug Delivery Rev., 2012, 64, 1663–1693.
2. Cohen, Y.; Rallo, R.; Liu, R.; Liu, H. H. In silico analysis of nano- materials hazard and risk. Acc. Chem. Res., 2013, 46, 802–812.
3. Vrontaki, E.; Mavromoustakos, T.; Melagraki, G.; Afantitis, A. Quantitative Nanostructure-Activity Relationship models for the Risk Assessment of NanoMaterials. In Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment; Roy, K., Ed.; IGI Global: Hershey, PA, 2015; pp 537–561.
4. Winkler, D.A.; Mombelli, E.; Pietroiusti, A.; Tran, L.; Worth, A.; Fadeel, B.; McCall, M.J. Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential. Toxicology, 2013, 313, 15–23.
5. Roca, C.P.; Rallo, R.; Fernández, A.; Giralt, F. Nanoinformatics for safe-by-design engineered nanomaterials. In Towards Efficient Designing of Safe Nanomaterials: Innovative Merge of Computational Approaches and Experimental Techniques; Leszczynski, J., Puzyn, T., Eds.; RSC Nanoscience and Nanotechnology: Cambridge, UK, 2012; pp 89–107.
6. Rasulev, B.; Gajewicz, A.; Puzyn, T.; Leszczynska, D.; Leszczyn- ski, J. Nano-QSAR: Advances and challenges. In Towards Efficient Designing of Safe Nanomaterials: Innovative Merge of Computational Approaches and Experimental Techniques; Leszczynski, J., Puzyn, T., Eds.; RSC Nanoscience and Nanotechnology: Cambridge, UK, 2012; pp 220–256.
7. Kleandrova, V.V.; Luan, F.; Gonzalez-Diaz, H.; Ruso, J.M.; Melo, A.; Speck-Planche, A.; Cordeiro, M.N.D.S. Computational eco-toxicology: Simultaneous prediction of ecotoxic effects of nanopar-ticles under different experimental conditions. Environ. Int., 2014, 73, 288–294.
8. Kleandrova, V.V.; Luan, F.; Gonzalez-Diaz, H.; Ruso, J.M.; Speck- Planche, A.; Cordeiro, M.N.D.S. Computational tool for risk assessment of nanomaterials: Novel QSTR-perturbation model for simultaneous prediction of ecotoxicity and cytotoxicity of uncoated and coated nanoparticles under multiple experimental conditions. Environ. Sci. Technol., 2014, 48, 14686–14694.
9. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Ds Cordeiro, M.N.D.S. Computational modeling in nanomedicine: prediction of multiple antibacterial profiles of nanoparticles using a quantitative structure-activity relationship perturbation model. Nanomedicine (Lond), 2015, 10, 193–204.
10. Melagraki, G.; Afantitis, Α.; Sarimveis, H.; Koutentis, P.A.; Ig-glessi- Markopoulou, O.; Kollias, G. In Silico Exploration for Identifying Structure–Activity Relationship of MEK Inhibition and Oral Bioavailability for Isothiazole Derivatives. Chem. Biol. Drug Des., 2010, 76, 397–406.
11. Melagraki, G.; Αfantitis, Α.; Sarimveis, H.; Igglessi-Markopoulou, O.; Alexandridis, A. A novel RBF neural network training methodology to predict toxicity to Vibrio Fischeri. Mol. Divers., 2006, 10, 213–221.
12. Zhang, L.; Sedykh, A.; Tripathi, A.; Zhu, H.; Afantitis, A.; Mouch-lis, V. D.; Melagraki, G.; Rusyn, I.; Tropsha, A. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches. Toxicol. Appl. Pharmacol., 2013, 272(1), 67–76.
13. Papa, E.; Kovarich, S.; Gramatica, P. Development, Validation and Inspection of the Applicability Domain of QSPR Models for Phys-icochemical Properties of Polybrominated Diphenyl Ethers. QSAR Comb. Sci., 2009, 28, 790–796.
14. Melagraki, G.; Afantitis, A. Enalos InSilicoNano Platform: An online decision support tool for the design and virtual screening of nanoparticles. RSC Adv., 2014, 4, 50713–50725.
15. Shao, C.-Y.; Chen, S.-Z.; Su, B.-H.; Tseng, Y.J.; Esposito, E.X.; Hopfinger, A.J. Dependence of QSAR models on the selection of trial descriptor sets: A demonstration using nanotoxicity endpoints of decorated nanotubes. J. Chem. Inf. Model., 2013, 53, 142–158.
16. Winkler, D.A.; Burden, F.R.; Yan, B.; Weissleder, R.; Tassa, C.; Shaw, S.; Epa, V.C. Modelling and predicting the biological effects of nanomaterials. SAR QSAR Environ. Res., 2014, 25, 161–172.
17. Toropov, A.A.; Toropova, A.P.; Puzyn, T.; Benfenati, E.; Gini, G.; Leszczynska, D.; Leszczynski, J. QSAR as a random event: Modeling of nanoparticles uptake in PaCa2 cancer cells. Chemos-phere, 2013, 92, 31–37.
18. Liu, R.; Rallo, R.; George, S.; Ji, Z.; Nair, S.; Nel, A.E.; Cohen, Y. Classification NanoSAR development for cytotoxicity of metal oxide nanoparticle. Small, 2011, 7, 1118–1126.
19. Liu, R.; Zhang, H.Y.; Ji, Z.X.; Rallo, R.; Xia, T.; Chang, C.H.; Nel, A.; Cohen, Y. Development of structure-activity relationship for metal oxide nanoparticles. Nanoscale, 2013, 5, 5644–5653.
20. Zhang, H.; Ji, Z.; Xia, T.; Meng, H.; Low-Kam, C.; Liu, R.; Pok-hrel, S.; Lin, S.; Wang, X.; Liao, Y.-P.; Wang, M.; Li, L.; Rallo, R.; Damoiseaux, R.; Telesca, D.; Mädler, L.; Cohen, Y.; Zink, J. I.; Nel, A.E. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano, 2012, 6, 4349–4368.
21. Fourches, D.; Pu, D.; Tropsha, A. Exploring Quantitative Nanos-tructure-Activity Relationships (QNAR) Modeling as a Tool for Predicting Biological Effects of Manufactured Nanoparti-cles. Comb. Chem. High Throughput Screening, 2011, 14, 217–225.
22. Fourches, D.; Pu, D.Q.Y.; Tassa, C.; Weissleder, R.; Shaw, S.Y.; Mumper, R.J.; Tropsha, A. Quantitative Nanostructure Activity Relationship Modeling. ACS Nano, 2010, 4, 5703–5712.
23. Shaw, S.Y.; Westly, E.C.; Pittet, M.J.; Subramanian, A.; Schreiber, S.L.; Weissleder, R. Perturbational Profiling of Nanomaterial Biologic Activity. Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 7387–7392.
24. Epa, V.C.; Burden, F.R.; Tassa, C.; Weissleder, R.; Shaw, S.; Win-kler, D.A. Modeling Biological Activities of Nanoparticles. Nano Lett., 2012, 12, 5808-5812.
25. Puzyn, T.; Rasulev, B.; Gajewicz, A.; Hu, X.; Dasari, T. P.; Michalkova, A.; Hwang, H.-M.; Toropov, A.; Leszczynska, D.; Leszczynski, J. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol., 2011, 6, 175–178.
26. Toropov, A.A.; Toropova, A.P.; Benfenati, E.; Gini, G.; Puzyn, T.; Leszczynska, D.; Leszczynski, J. Novel application of the CORAL software to model cytotoxicity of metal oxide nanoparticles to bacteria Escherichia coli. Chemosphere, 2012, 89, 1098–1102.
27. Sayes, C.; Ivanov, I. Comparative Study of Predictive Computational Models for Nanoparticle-Induced Cytotoxicity. Risk Analysis, 2010, 30(11), 1723–1734.
28. Toropova, A.P.; Toropov, A.A. Optimal descriptor as a translator of eclectic information into the prediction of membrane damage by means of various TiO2 nanoparticles. Chemosphere, 2013, 93, 2650–2655.
29. Liu, R.; Rallo, R.; Weissleder, R.; Tassa, C.; Shaw, S.; Cohen, Y. Nano-SAR development for bioactivity of nanoparticles with considerations of decision boundaries. Small, 2013, 9, 1842–1852.
30. Luan, F.; Kleandrova, V.V.; González-Díaz, H.; Ruso, J.M.; Melo, A.; Speck-Planche, A.; Cordeiro, M.N.D.S. Computer-aided nano-toxicology: assessing cytotoxicity of nanoparticles under diverse experimental conditions by using a novel QSTR-perturbation approach. Nanoscale, 2014, 6(18), 10623–10630.
31. Kar, S.; Gajewicz, A.; Puzyn, T.; Roy, K.; Leszczynski, J. Periodic table-based descriptors to encode cytotoxicity profile of metal oxide nanoparticles: A mechanistic QSTR approach. Ecotoxicol. Environ. Saf., 2014, 107, 162–169.
32. Tetko, I. V. The perspectives of computational chemistry modeling. J. Comput. Aided Mol. Des. 2012, 26, 135–136.
33. Berthold, M.R.; Cebron, N.; Dill, F.; Gabriel, T.R.; Kotter, T.; Meinl, T.; Ohl, P.; Sieb, C.; Thiel, K.; Wiswedel, B. KNIME: The Konstanz Information Miner. In Studies in Classification, Data Analysis, and Knowledge Organization; Preisach, C., Burkhardt, H., Schmidt-Thieme, L., Decker, R. Eds.; GfKl; Springer: Berlin, Heidelberg, 2007; pp 319–326.
34. Melagraki, G.; Afantitis, A. Enalos KNIME nodes: Exploring corrosion inhibition of steel in acidic medium. Chemom. Intell. Lab. Syst., 2013, 123, 9–14.
35. http://www.novamechanics.com/knime.php (accessed Month Day, Year).
36. Witten, I.H.; Frank, E. Data Mining: Practical Machine Learning Tools and Techniques, 2nd Edition, The Morgan Kaufmann Series in Data Management Systems, Gray, J., Microsoft Research, Eds.; Elsevier: San Francisco, CA 2005; 1–525.
37. Hall, M.; Frank, E.; Holmes, G.; Pfahringer, B.; Reutemann, P.; Witten, I. H. The WEKA Data Mining Software: An Update. SIGKDD Explorations, 2009, 11(1), 10–18.
38. Geng, X.; Liu, T.-Y.; Qin, T.; Li, H. Feature selection for ranking. In SIGIR’07: Proceedings of the 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, New York, NY, USA, ACM, 2007; 407–414.
39. OECD Principles for the validation, for regulatory purposes of (Quantitative) Structure Activity Relationship Models. http://www.oecd.org/ (accessed 12/20/2013).
40. Afantitis, A.; Melagraki, G.; Koutentis, P.A.; Sarimveis, H.; Kol-lias, G. Ligand - based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen Maps and Counterpropagation Artificial Neural Networks, Eur. J. Med. Chem., 2011, 46, 497–508.
41. Mouchlis, V.D.; Melagraki, G.; Mavromoustakos, T.; Kollias, G.; Afantitis, A. Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: An integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoM-SIA. J. Chem. Inf. Model., 2012, 52, 711–723.
42. Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inf. 2010, 29, 476–488.
43. Afantitis, A.; Melagraki, G.; Sarimveis, H.; Koutentis, P. A.; Markopoulos, J.; Igglessi-Markopoulou, O. Development and evaluation of a QSPR model for the prediction of diamagnetic susceptibility. QSAR Comb. Sci., 2008, 27, 432–436.
44. Zhang, S.; Golbraikh, A.; Oloff, S.; Kohn, H.; Tropsha, A. Novel Automated Lazy Learning QSAR (ALL-QSAR) Approach: Method Development, Applications, and Virtual Screening of Chemical Databases Using Validated ALL-QSAR Models. J. Chem. Inf. Model., 2006, 46, 1984–1995.
45. Liu, H.; Yao, X.; Gramatica, P. The applications of machine learning algorithms in the modeling of estrogen-like chemicals. Comb. Chem. High Throughput Screening, 2009, 12, 490–496.
46. Melagraki, G.; Afantitis, Α.; Sarimveis, H.; Koutentis, P.A.; Markopoulos, J.; Igglessi-Markopoulou, O. A novel QSPR model to predict θ (lower critical solution temperature) in polymer solutions using molecular descriptors. J. Mol. Model., 2007, 13, 55–64.
47. Enalos InSilicoTox Platform.http://www.insilicotox.com/ (accessed 12/20/2013).
48. Enalos InSilicoNano Platform. http://enalos.insilicotox.com/ QNAR_IronOxide_Toxicity/ (accessed 12/20/2013).
49. Vrontaki, E.; Melagraki, G.; Mavromoustakos, T.; Afantitis, A. Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors. Methods, 2015, 71, 4–13.